相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells
Zhen Lu et al.
AUTOPHAGY (2014)
Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA
Ulrike Heinicke et al.
CANCER LETTERS (2014)
MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor- κB1/MMP9 signaling pathway
Tian-Quan Yang et al.
CANCER SCIENCE (2014)
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7
Z. Lu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Necroptosis: Who Knew There were so Many Interesting Ways to Die?
S. M. Fayaz et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
ARHI Overexpression Induces Epithelial Ovarian Cancer Cell Apoptosis and Excessive Autophagy
Jie Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary
Hiroaki Itamochi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts
S. L. Locatelli et al.
LEUKEMIA (2014)
Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor
J. Ma et al.
CELL DEATH & DISEASE (2014)
The Expression of Bcl-2 and BID in Gastric Cancer Cells
Mariusz Gryko et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Tissue transglutaminase: a new target to reverse cancer drug resistance
Alfredo Budillon et al.
AMINO ACIDS (2013)
The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration
Mirko Klingauf et al.
BIOLOGY OF THE CELL (2013)
TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
Francisco J. Roca et al.
CELL (2013)
Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
Angela J. Ziebarth et al.
CLINICAL CANCER RESEARCH (2013)
Platinum-Based Agents for Individualized Cancer Treatment
X. Chen et al.
CURRENT MOLECULAR MEDICINE (2013)
Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance
Francesca Aredia et al.
FUTURE MEDICINAL CHEMISTRY (2013)
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S. Jouan-Lanhouet et al.
CELL DEATH AND DIFFERENTIATION (2012)
Differential Diagnosis of a Pelvic Mass Improved Algorithms and Novel Biomarkers
Robert C. Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
D. B. Badgwell et al.
ONCOGENE (2012)
TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations
Yechen Xiao et al.
BLOOD (2011)
MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer
Yi Chen et al.
CANCER PREVENTION RESEARCH (2011)
Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy-induced Cell Death through Autophagy Induction and Down-regulation of p62/Sequestosome 1
Shengbing Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanisms of necroptosis in T cells
Irene L. Ch'en et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins
Shaoyi Huang et al.
BIOSCIENCE REPORTS (2010)
Autophagy in aging, disease and death: the true identity of a cell death impostor
B. Levine et al.
CELL DEATH AND DIFFERENTIATION (2009)
Apoptosis and autophagy: Targeting autophagy signalling in cancer cells -'trick or treats'?
Elisabeth A. Corcelle et al.
FEBS JOURNAL (2009)
ARHI, As a Novel Suppressor of Cell Growth and Downregulated in Human Hepatocellular Carcinoma, Could Contribute to Hepatocarcinogenesis
Jian Huang et al.
MOLECULAR CARCINOGENESIS (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation
Weiwei Feng et al.
CANCER (2008)
FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells
Bryan D. Bell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors
Irene Dalai et al.
NEOPLASIA (2007)
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor
Weisheng Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
LMO4 can interact with Smad proteins and modulate transforming growth factor-β signaling in epithelial cells
Z. Lu et al.
ONCOGENE (2006)
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer
Z Lu et al.
CLINICAL CANCER RESEARCH (2006)
Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis
F Weber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival
DG Rosen et al.
CLINICAL CANCER RESEARCH (2004)
Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor
ZY Yue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers
RZ Luo et al.
ONCOGENE (2003)
The triterpenoid CDDO induces apoptosis in refractory CLL B cells
IM Pedersen et al.
BLOOD (2002)
ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis
H Hisatomi et al.
ONCOLOGY (2002)
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
N Holler et al.
NATURE IMMUNOLOGY (2000)
分享论文
